The stock currently offers a 4% dividend yield ... We can see from my table above that Sanofi is undervalued by 55% to peers ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... 23 abstracts at the American Society of ...

Shares of NASDAQ SNY opened at $50.14 on Wednesday. The stock has a market cap of $127.25 billion, a PE ratio of 25.83, a ...

RFK Jr. has developed a reputation as a vaccine skeptic and pushed conspiracy theories including one linking vaccines to ...

On Tuesday, Novavax Inc (NASDAQ:NVAX) reported third-quarter 2024 sales of $84.5 million, compared to $186.99 million a year, ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

today and set a price target of £114.00. The company’s shares opened today at p10,290.00. Welford covers the Healthcare sector, focusing on stocks such as Sanofi, GlaxoSmithKline, and Novartis.

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

The highest price of Sanofi Consumer Healthcare India Ltd stock is ₹5,375.00 in the last 52-week. What is the share price of Sanofi Consumer Healthcare India Ltd (SANOFICONR) today on NSE?